United Therapeutics Corp. (UTHR)

123.42
0.31 0.25
NASDAQ : Health Technology
Prev Close 123.11
Open 123.36
Day Low/High 122.82 / 125.13
52 Wk Low/High 100.57 / 152.55
Volume 265.22K
Avg Volume 345.90K
Exchange NASDAQ
Shares Outstanding 43.56M
Market Cap 5.29B
EPS 9.50
P/E Ratio 7.52
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CNNE, GWRE, MDRX, VRA Downgrades: PDFS, RE, SB, SGRP, UTHR Initiations: CODX, NETS Read on to get TheStreet Quant Ratings' detailed report:

United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products

United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products

Exclusive license agreement for Treprostinil Technosphere®; $95 million in upfront and milestone payments

United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.

United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.

SILVER SPRING, Md., Aug.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: LGL, UTHR Downgrades: CKX, ERF, GORO, GTS, XNET Initiations: TPNL Read on to get TheStreet Quant Ratings' detailed report:

United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso

United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint

United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

United Therapeutics Corporation Reports Second Quarter 2018 Financial Results

United Therapeutics Corporation Reports Second Quarter 2018 Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.

HSR Act Waiting Period Terminated For United Therapeutics' Acquisition Of SteadyMed Ltd.

HSR Act Waiting Period Terminated For United Therapeutics' Acquisition Of SteadyMed Ltd.

SILVER SPRING, Md. and SAN RAMON, Calif.

5 Bearish Bets: Why Pepsi, Cray and 3 Other Stocks Look Good Short

5 Bearish Bets: Why Pepsi, Cray and 3 Other Stocks Look Good Short

Pepsi looks challenged and Cray's chart is 'cray cray.'

Pepsi Is Challenged, Cray’s Chart Is Cray Cray and 3 Other Stocks That Look Good Short

PEP, CULP, IT, CRAY and UTHR were all recently were downgraded by TheStreet's Quant Ratings service.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOI, ATSG, CKH, CRM, DDS, EQBK, FSTR, GNK, NEWM, OAS, RDC, RRC, TCMD, UHS, WTW Downgrades: AHGP, AMED, AXE, CTRE, CULP, DOC, EMKR, GLW, HABT, IT, KBR, RP, SGEN, SPOK, SWM, TACO, UGP, UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against United Therapeutics Corporation - UTHR

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of United Therapeutics Corporation (NASDAQ: UTHR) resulting from allegations that United...

Faruqi & Faruqi, LLP Is Investigating United Therapeutics Corporation (UTHR) On Behalf Of Its Shareholders

Faruqi & Faruqi, LLP Is Investigating United Therapeutics Corporation (UTHR) On Behalf Of Its Shareholders

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ:UTHR).

Short Interest Falls 20% For UTHR

Short Interest Falls 20% For UTHR

The most recent short interest data has been released for the 01/31/2018 settlement date, which shows a 1,169,886 share decrease in total short interest for United Therapeutics Corp , to 4,652,309, a decrease of 20.09% since 01/12/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Axovant Shares Crater as CEO and President Both Resign

Axovant Shares Crater as CEO and President Both Resign

Chief executive David Hung resigned from the Basel, Switzerland, biotech after just 10 months on the job.

Best Biotech Stock Trades and Mergers to Watch in 2018

Best Biotech Stock Trades and Mergers to Watch in 2018

Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.

United Therapeutics Gets a Quantitative Upgrade

United Therapeutics Gets a Quantitative Upgrade

Shares look to break out from long basing pattern.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHUY, KANG, NYCB, UTHR, WSTL Downgrades: DEL, LAKE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

An Ocean Shipper, a Biotech Concern and Other Stocks That Look Good Short

UTHR, ENZ, HCI, SBLK and EVI all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CAMP, HAL, HWBK Downgrades: UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Biotech Movers: Buzz on Potential Suitors Sends United Therapeutics Stock Soaring

Biotech Movers: Buzz on Potential Suitors Sends United Therapeutics Stock Soaring

GlaxoSmithKline could be among the suitors for United Therapeutics, the Evening Standard reported.

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NasdaqGS:UTHR).

TheStreet Quant Rating: C+ (Hold)